Evaluation of a polychemotherapeutic regimen including Idarubicin (4-demethoxydaunorubicin) in relapsed acute lymphocytic leukemia

Haematologica. 1986 Jan-Feb;71(1):34-8.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antibiotics, Antineoplastic / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / toxicity
  • Asparaginase / therapeutic use
  • Child
  • Child, Preschool
  • Clinical Trials as Topic
  • Cytarabine / therapeutic use
  • Daunorubicin / administration & dosage
  • Daunorubicin / analogs & derivatives*
  • Daunorubicin / therapeutic use
  • Female
  • Follow-Up Studies
  • Humans
  • Idarubicin
  • Leukemia, Lymphoid / drug therapy*
  • Male
  • Methotrexate / therapeutic use
  • Vincristine / therapeutic use

Substances

  • Antibiotics, Antineoplastic
  • Cytarabine
  • Vincristine
  • Asparaginase
  • Methotrexate
  • Idarubicin
  • Daunorubicin